Q4 2021 Eiger BioPharmaceuticals Inc Earnings Call Transcript

Mar 10, 2022 / 09:30PM GMT
Operator

Good day, ladies and gentlemen, and welcome to the Eiger BioPharmaceuticals Fourth Quarter and Full-Year 2021 Financial Results and Business Update Conference Call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. (Operator Instructions) As a reminder, this call will be recorded.

I would now like to introduce your host for today's conference, Mr. Sri Ryali, Chief Financial Officer of Eiger. You may begin.

Sri Ryali - Eiger BioPharmaceuticals Inc. - CFO

Good afternoon and thank you for joining us today. Welcome to our quarterly financial results and business update call. We issued a press release earlier this afternoon with our Q4 and full-year 2021 financial results, which is available on our website at eigerbio.com.

For today's call, we will have prepared remarks from the management team followed by Q&A. We will be using slides for the webcast and will have a replay available on the Investors section of our website.

Joining me

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot